Photocure announces resignation of Chief Operating Officer

Published: 26 May 2016Organisational Announcements

Oslo, Norway, 26 May 2016: Photocure ASA announces today that its Chief Operating Officer, Kathleen Deardorff, has resigned effective 1 June 2016 to pursue other career opportunities. Ms Deardorff has been with Photocure since 2011, serving as Chief Operating Officer during her entire tenure.

"During her five years at Photocure, Kathleen has made significant contributions to the company. She has been an important part of our management team and we wish her all the best in her future endeavours," says Kjetil Hestdal, M.D., Ph.D., President and CEO, Photocure ASA.

During the transition process and search for a suitable full-time successor is successfully fulfilled, Photocure will allocate the position's key operational duties to the current management team.

For further information, please contact:

President & CEO Kjetil Hestdal
Tel: + 47 913 19 535

CFO Erik Dahl
Tel: +47 450 55 000

Notes to editors

About Photocure ASA

Photocure, headquartered in Oslo Norway, is a specialty pharmaceutical company and world leader in photodynamic technology. Based on our unique proprietary Photocure Technology(TM) platform, Photocure develops and commercializes highly selective and effective solutions within disease areas with high unmet medical need, such as bladder cancer, HPV and precancerous cervical lesions, colorectal cancer and skin conditions. Our aim is to provide solutions which can improve health outcomes for patients worldwide. Photocure is listed on the Oslo Stock Exchange (OSE: PHO). Information about Photocure is available at

This information is subject of the disclosure requirements acc. to §5-12 vphl (Norwegian Securities Trading Act)

News and events